Solara Pharma Q2 Loss: ₹10 Crore Amid Challenges
Solara Active Pharma Sciences faces challenging quarter with ₹10 crore net loss despite revenue growth. Discover the operational challenges and management's recovery strategy.
Category : Search result: pharmaceutical earnings
Sun Pharma Q2 Profit Rises 2.5% to ₹3,118 Crore
India's pharmaceutical giant Sun Pharma reports steady Q2 growth with 9% revenue increase while navigating US market challenges. Key insights from their latest earnings report.
Q2 Results Today: Sun Pharma, Grasim, Britannia Earnings
Market eyes Wednesday's Q2 earnings bonanza as pharma giant Sun Pharma, Grasim Industries, and FMCG major Britannia declare results. Get complete analysis and investor expectations.
Adani Q2 Profits Soar 130% Despite Coal Trade Dip
Adani Enterprises reports stellar Q2 performance with 130% profit surge to ₹228 crore, driven by airport operations and green hydrogen initiatives, while coal trading faces headwinds.
AgentForce AI Revolutionizes Life Sciences Engagement in India
Discover how AgentForce's AI-powered platform is reshaping customer engagement in India's life sciences sector, eliminating burnout while boosting productivity by 40%.
Route Mobile Q2: ₹19 Crore Loss, Revenue Growth Stalls
CPaaS leader Route Mobile faces surprising Q2 setback with ₹19 crore loss versus last year's profit. Revenue growth stalls at 0.7% amid global economic pressures. Discover what went wrong.
Baddi Pharma Raid: Sub-Standard Medicines Shipped to Rajasthan
Himachal Pradesh drug control authorities raid Baddi pharmaceutical facility after Rajasthan complaints reveal distribution of sub-standard medicines across seven districts, raising serious public health concerns.
SBI, Adani Enterprises, Paytm Q2 Results Today - Stocks to Watch
Stock market braces for earnings tsunami as State Bank of India, Adani Enterprises, Mahindra & Mahindra, and Paytm parent One 97 Communications lead today's Q2 results declaration. Get complete analysis and market expectations.
Bharat Biotech enters cell & gene therapy with Nucelion
Indian vaccine maker Bharat Biotech expands into high-growth CRDMO space with new subsidiary Nucelion Therapeutics, focusing on cutting-edge cell and gene therapies for cancer and rare diseases.
Q2 Results: Bharti Airtel, Titan, Power Grid Earnings Today
Major Indian companies including Bharti Airtel, Titan Company, and Power Grid Corporation are set to declare their Q2 FY2025 earnings today. Get insights into market expectations, key metrics to watch, and how these results could impact your investment de
Indian Exports to US Crash 37.5% Amid Trump Tariffs
Indian exports to the US plummeted 37.5% amid 50% Trump tariffs, with smartphones and pharmaceuticals taking the biggest hit. Get the complete trade impact analysis.
US Tariffs Crush Indian Exports: 37.5% Plunge
GTRI report reveals devastating 37.5% decline in India's key exports to US, with smartphones, pharmaceuticals, and gems taking the hardest hit from American tariff policies.
Wall Street Eyes Q3 Earnings Amid Record Government Shutdown
As the US government shutdown extends to record length, Wall Street shifts focus to Q3 corporate earnings. Discover how this political stalemate impacts market sentiment and investor strategy.
Q2 Earnings: Airtel, SBI, LIC, Paytm, Adani Results Next Week
Get ready for a blockbuster week in Indian markets as corporate giants including Bharti Airtel, SBI, LIC, Paytm, and Adani Enterprises declare their Q2 FY2025 results. Discover key expectations and market-moving insights.
Q2 Results 2025: Urban Company, Tata Chemicals Among 27 Earnings
Stock market investors brace for major Q2 earnings announcements as Urban Company, Tata Chemicals and 25 other companies set to reveal financial performance today. Get complete list and analysis.
FDA Recalls Blood Pressure Meds Over Cancer Risk
Multiple blood pressure medications recalled after FDA detects potential cancer-causing impurities. Find out if your medication is affected and what steps to take immediately.
Health Biotech Expands Global Presence at CPhI Frankfurt
Indian biopharmaceutical leader Health Biotech Limited makes waves at CPhI Frankfurt 2025, showcasing innovative products and forging international partnerships to strengthen its global market position.
Niner Pharma Expands R&D with 125 New Peptide Molecules
Chandigarh-based Niner Pharma announces massive R&D expansion with 125 novel peptide molecules targeting wellness and cosmetic innovation, positioning India as global leader in peptide research.
Q2 Results: Maruti, Vedanta, BPCL, GAIL, BEL Earnings
Major Indian companies including Maruti Suzuki, Vedanta, BEL, BPCL, and GAIL are announcing their Q2 FY2025 earnings today. Get insights on expected performance, key financial indicators, and market impact analysis.
Apple Hits ₹8.5L Cr Revenue as iPhone 17 Sales Soar
Apple's Q4 earnings reveal massive ₹8.5 lakh crore revenue and ₹2.3 lakh crore profit as iPhone 17 sales explode. Discover how India's premium smartphone market is fueling this historic growth.
Cipla CEO Change: Achin Gupta Succeeds Umang Vohra
Indian pharmaceutical giant Cipla reveals strategic leadership transition with Achin Gupta succeeding Umang Vohra as Global CEO in September 2024, marking a new era for the company.
FDA Recalls 580K Blood Pressure Meds Over Cancer Risk
Major pharmaceutical recall alert: FDA discovers carcinogenic impurity in popular blood pressure medications, affecting hundreds of thousands of patients across the US. Safety concerns prompt immediate withdrawal.
Eli Lilly Ups Forecast as Zepbound Demand Soars
Pharmaceutical giant Eli Lilly raises full-year profit forecast as demand skyrockets for revolutionary weight-loss treatment Zepbound, sending shares climbing 7%.
Cipla Shares Fall 4% After Q2 Results
Cipla's stock faced significant pressure after Q2 FY2025 results revealed margin pressures despite revenue growth. Discover the key factors behind the 4% decline and what analysts are saying about the pharmaceutical giant's future prospects.
Q2 Results: ITC, Swiggy, NTPC, Adani Power Earnings Today
Major Indian companies including ITC, Swiggy, NTPC, and Adani Power declare Q2 earnings today. Get insights into market expectations and performance analysis.
Punjab de-addiction centres sold pills in black market: ED probe
Shocking probe reveals Punjab doctor's de-addiction centres allegedly operated pill trafficking network while claiming to treat addiction. ED uncovers massive pharmaceutical diversion scheme.
Google's AI Boom Fuels Record $102B Q3 Revenue
Alphabet's Q3 2024 earnings smash expectations as artificial intelligence drives unprecedented growth across Google's advertising and cloud divisions, marking a stunning tech comeback.
Meta Profits Crash 52% on $16B Trump Tax Charge
Meta Platforms reports staggering 52% profit decline in Q3 earnings, hit by massive $16 billion legal charge from Trump administration legislation. Revenue growth continues despite Reality Labs losses.
India Bans Fraudulent Pharma Licenses in Major Reform
India implements sweeping regulatory reforms to combat fraudulent pharmaceutical manufacturing licenses, enhancing drug safety standards for domestic and international markets including US and EU.
Coal India Q2 profit plunges 32% due to heavy rains
Coal India reports significant 32% drop in Q2 net profit amid production challenges caused by excessive rainfall. Revenue declines 3% as operations face weather-related hurdles.
Page 1 of 4